Sort
15,842 grants matching “pancreatic cancer”
PROJECT 4: Targeting Methionine Adenosyltransferases in Liver Metastasis
$337,611Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Integration of stromal targeting agents with immune checkpoint therapy
$337,607Lei Zheng · Johns Hopkins University · P01 · FY2023 · CA
Biospecimen Acquisition, Processing and Classification Unit
$337,605Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · U2C · FY2020 · CA
Mutant p53 as actionable cancer-specific target
$337,545Ute M Moll · State University New York Stony Brook · R01 · FY2022 · CA
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
$337,470Amy E Wright · Florida Atlantic University · R01 · FY2010 · CA
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
$337,420Laurence H Hurley · University Of Arizona · R01 · FY2014 · CA
SLC6A14 as a unique drug target to treat pancreatic cancer
$337,342Yangzom Doma Bhutia · Texas Tech University Health Scis Center · R01 · FY2024 · CA
Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer
$337,341Chang-Il Hwang · University Of California At Davis · R37 · FY2024 · CA
Biological activity of ras oncogenes
$337,334University Of North Carolina Chapel Hill · R01 · FY2005 · CA
Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
$337,327Ke Sheng · University Of California Los Angeles · R01 · FY2016 · CA
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy
$337,227Weiqin Lu · University Of Texas El Paso · R01 · FY2023 · CA
Core B: Liver Metastasis Resource Core (LMRC)
$337,190Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2023 · CA
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
$337,151William G Hawkins · Washington University · R01 · FY2013 · CA
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids
$337,036Richard R Drake · Medical University Of South Carolina · R33 · FY2022 · CA
Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
$337,028Ke Sheng · University Of California Los Angeles · R01 · FY2017 · CA
Determinants of AGR2 effects in Barrett's esophagus and esophageal adenocarcinoma
$337,010Anson W Lowe · Stanford University · R01 · FY2009 · DK
Centroacinar progenitors in mouse and zebrafish pancreas
$336,897Steven D Leach · Johns Hopkins University · R01 · FY2012 · DK
Centroacinar progenitors in mouse and zebrafish pancreas
$336,897Steven D Leach · Johns Hopkins University · R01 · FY2011 · DK
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
$336,881William G Hawkins · Washington University · P50 · FY2023 · CA
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
$336,835Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2024 · CA
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
$336,835Pei Wang · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Advanced Oncolytic Adenovirus Enabling Systemic Therapy of PDAC
$336,835Masato Yamamoto · University Of Minnesota · R01 · FY2024 · CA
Targeting KSR to Treat Pancreatic Cancer
$336,747Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Development, cellular plasticity and homeostasis of the exocrine pancreas
$336,725Beatriz Sosa-Pineda · Northwestern University At Chicago · R01 · FY2016 · DK
Development, cellular plasticity and homeostasis of the exocrine pancreas
$336,725Beatriz Sosa-Pineda · Northwestern University At Chicago · R01 · FY2017 · DK